QGEN vs RGEN: stock comparison and AI forecast
Qiagen N.V. (QGEN) and Repligen Corp (RGEN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
QGEN Qiagen N.V.
- Market Cap
- $10.92B
- P/E Ratio
- 35.7x
- Size
- large-cap
- AI Forecast
RGEN Repligen Corp
- Market Cap
- $11.06B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- QGEN and RGEN have similar market capitalizations ($10.92B and $11.06B).
- QGEN carries 0.66 times debt per unit of equity, against 0.40 times for RGEN.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | QGEN | RGEN |
|---|---|---|
| Market Cap | $10.92B | $11.06B |
| P/E Ratio | 35.71x | – |
| P/B Ratio | 2.89x | 5.29x |
| EPS | $1.41 | $-0.08 |
| Book Value/Share | $17.42 | $32.71 |
| Revenue/Share | – | $12.60 |
| FCF/Share | – | $1.67 |
Profitability & Margins
| Metric | QGEN | RGEN |
|---|---|---|
| ROE | 8.4% | – |
| ROA | 5.1% | – |
| ROIC | 6.5% | 0.7% |
| Gross Margin | 59.8% | 53.8% |
| Operating Margin | 18.4% | 2.3% |
| Net Margin | 15.6% | – |
| EBT Margin | 19.0% | 1.0% |
| Tax Rate | 18.1% | 243.4% |
Financial Health
| Metric | QGEN | RGEN |
|---|---|---|
| Current Ratio | 3.90x | 9.88x |
| Quick Ratio | 3.31x | 8.43x |
| D/E Ratio | 0.66x | 0.40x |
| Financial Leverage | 1.66x | 1.40x |
| Interest Coverage | 15.9x | – |
| Working Capital | $1.48B | $1.12B |
Cash Flow
| Metric | QGEN | RGEN |
|---|---|---|
| Operating Cash Flow | $626M | $130M |
| Free Cash Flow | – | $107M |
| Capital Spending | – | -$23M |
| OCF Growth YoY | 40.0% | -0.8% |
| FCF Growth YoY | – | -3.0% |
| FCF/Sales | – | 13.2% |
| CapEx/Sales | – | 2.9% |
Operational Efficiency
| Metric | QGEN | RGEN |
|---|---|---|
| Asset Turnover | – | 0.28x |
| Receivables Turnover | – | 5.3x |
| Inventory Turnover | 2.7x | 2.0x |
| Fixed Assets Turnover | – | 4.9x |
| Days Sales Outstanding | – | 69 days |
| Days Inventory | 134 days | 179 days |
| Payables Period | 32 days | 27 days |
| Cash Conversion Cycle | – | 220 days |
Income Statement
| Metric | QGEN | RGEN |
|---|---|---|
| Total Revenue | – | $806M |
| Operating Income | $376M | $18M |
| Net Income | $318M | – |
| R&D Expense | $192M | $56M |
| SG&A Expense | $678M | $311M |
| Cost of Goods Sold | $822M | $372M |
Dividend & Shareholder Information
| Metric | QGEN | RGEN |
|---|---|---|
| Shares Outstanding | 217M | 64M |
| EPS Growth | 28.5% | – |
QGEN vs RGEN: stock comparison and AI forecast
Which is bigger, QGEN or RGEN?
QGEN and RGEN have similar market capitalizations ($10.92B and $11.06B).
Which one does Intratio's AI model rank higher, QGEN or RGEN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.